EMCORE CORP
10-Q, 1998-02-17
ELECTRONIC COMPONENTS & ACCESSORIES
Previous: IFS INTERNATIONAL INC, 8-K, 1998-02-17
Next: WARBURG PINCUS NEW YORK INTERMEDIATE MUNICIPAL FUND, 485BPOS, 1998-02-17





                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM 10-Q


(Markone):  

[X]  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
     ACT OF 1934

                For the quarterly period ended December 31, 1997

OR

[ ]  TRANSITION  REPORT  PURSUANT  TO  SECTION  13  OR  15(d) OF THE  SECURITIES
     EXCHANGE ACT OF 1934

           For the transition period from ____________ to ___________

                         Commission File Number: 0-22175

                               EMCORE CORPORATION
             (Exact name of Registrant as specified in its charter)

                                   NEW JERSEY
         (State or other jurisdiction of incorporation or organization)

                                   22-2746503
                        (IRS Employer Identification No.)

                              394 ELIZABETH AVENUE
                               SOMERSET, NJ 08873
               (Address of principal executive offices) (zip code)

                                 (732) 271-9090
              (Registrant's telephone number, including area code)


     Indicate  by check mark  whether the  registrant  (1) has filed all reports
required to be filed by Section 13 or 15 (d) of the  Securities  Exchange Act of
1934  during  the  preceding  12 months  (or for such  shorter  period  that the
registrant was required to file such reports),  and (2) has been subject to such
filing requirements for the past 90 days.
Yes [X]   No [ ]

     The number of shares  outstanding of the  registrant's  no par value common
stock as of February 13, 1998 was 9,321,107.

<PAGE>

PART I. FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

                               EMCORE CORPORATION
                 CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
                      (IN THOUSANDS, EXCEPT PER SHARE DATA)
                                   (Unaudited)

                                                       THREE MONTHS ENDED
                                                          DECEMBER 31,
                                                      1997            1996
                                                 --------------------------
Revenue                                             $12,357         $8,591

Cost of sales                                         6,376          6,724
                                                 --------------------------

Gross profit                                          5,981          1,867
                                                 --------------------------

Operating expenses:
  Selling, general and administrative                 3,074          2,202
  Research and development:
    Acquired in-process research & development       29,294
    Recurring research & development                  2,836          2,250
                                                 --------------------------
Total operating expenses                             35,204          4,452
                                                 --------------------------

Operating loss                                      (29,223)        (2,585)
                                                 --------------------------

Other expense:
  Stated interest expense                                70            197
  Imputed warrant interest expense, non-cash.            96          1,016
                                                 --------------------------
Total other expense                                     166          1,213
                                                 --------------------------

Net loss                                           ($29,389)       ($3,798)
                                                 ==========================

Earnings per common share -- basic                   ($4.15)        ($1.27)
                                                 ==========================

Earnings per common share -- diluted                 ($4.15)        ($0.86)
                                                 ==========================

The  accompanying  notes are an integral  part of these  condensed  consolidated
financial statements.



<PAGE>

                               EMCORE CORPORATION
                      CONDENSED CONSOLIDATED BALANCE SHEET
                                 (IN THOUSANDS)

<TABLE>
<CAPTION>
                                                                                (UNAUDITED)
                                                                                DECEMBER 31,    SEPTEMBER 30,
                                                                                    1997            1997
                                                                                ------------    -------------
<S>                                                                             <C>             <C>
                                        ASSETS
Cash and cash equivalents                                                            $3,301           $3,653
Restricted cash                                                                         250              313
Accounts receivable, net of allowance for doubtful accounts
            of approximately $707 and $697 at December 31, 1997 and
            September 30, 1997, respectively                                          7,857            8,439
Accounts receivable, related party                                                    2,000            2,500
Inventories, net                                                                      9,168            7,186
Other current assets                                                                    482              120
                                                                                ------------    -------------
    Total current assets                                                             23,058           22,211

Property and equipment, net                                                          19,242           16,798
Other assets                                                                          3,839              454
                                                                                ------------    -------------
    Total assets                                                                    $46,139          $39,463
                                                                                ============    =============

                          LIABILITIES & SHAREHOLDERS' EQUITY
Current liabilities:
    Accounts payable                                                                 $6,924           $4,050
    Accrued expenses                                                                  3,621            3,868
    Advanced billings                                                                 1,193            1,998
    Capital lease obligation, current portion                                           613               15
    Other current liabilities                                                            31              124
                                                                                ------------    -------------
     Total current liabilities                                                       12,382           10,055

Subordinated notes, net                                                               7,551            7,499
Capital lease obligation, net of current portion                                      1,252               78
                                                                                ------------    -------------
     Total liabilities                                                               21,185           17,632
                                                                                ------------    -------------

SHAREHOLDERS' EQUITY:
    Common stock, no par value,  23,529,411 shares authorized,  
         9,319,287 shares issued and outstanding December 31, 1997,
         6,000,391 shares issued and outstanding September 30, 1997                  85,787           45,817
    Accumulated deficit                                                             (53,166)         (23,777)
    Notes receivable from warrant issuances and stock sales                          (7,667)            (209)
                                                                                ------------    -------------

    Total shareholders' equity                                                       24,954           21,831
                                                                                ------------    -------------

    Total liabilities and shareholders' equity                                      $46,139          $39,463
                                                                                ============    =============
</TABLE>

The  accompanying  notes are an integral  part of these  condensed  consolidated
financial statements.





<PAGE>




                               EMCORE CORPORATION
                 CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
                                 (IN THOUSANDS)
                                   (Unaudited)
<TABLE>
<CAPTION>

                                                                                      THREE MONTHS ENDED
                                                                                         DECEMBER 31,
                                                                                   1997              1996
                                                                                 ---------         --------
<S>                                                                              <C>               <C>
OPERATING ACTIVITIES:
Net loss                                                                         ($29,389)         ($3,798)
                                                                                 ---------         --------
Adjustments to reconcile net loss to net cash
  provided by (used in) operating activities  
  Depreciation and amortization                                                     1,601            1,017
  Acquired in-process research and development, non-cash                           29,294
  Compensatory stock issuances                                                         88
  Provision for doubtful accounts                                                      10               60
  Detachable warrant accretion and valuation                                           97            3,716
  Provision for inventory valuation                                                    30               60
  Change in assets and liabilities:
    Accounts receivable                                                             1,191           (3,662)
    Inventories                                                                    (1,876)          (1,722)
    Costs in excess of billings on uncompleted contracts                             (146)             (38)
    Other current assets                                                             (194)              17
    Other assets                                                                      (93)          (2,891)
    Accounts payable                                                                2,851            1,065
    Accrued expenses                                                               (1,546)             269
    Advanced billings                                                                (806)           1,609
    Other current liabilities                                                         (93)             (12)
                                                                                 ---------         --------
Total adjustments                                                                  30,408             (512)
                                                                                 ---------         --------
  Net cash provided by (used in) operating activities                               1,019           (4,310)
                                                                                 ---------         --------
INVESTING ACTIVITIES:
Purchase of property, plant, and equipment                                         (1,627)          (1,156)
Acquisition, cash acquired                                                            193
Payments on restricted cash                                                            63
                                                                                 ---------         --------
  Net cash used in investing activities                                            (1,371)          (1,156)
                                                                                 ---------         --------
FINANCING ACTIVITIES:
Payments on notes payable and long-term debt                                          (50)
Proceeds from borrowings under demand note facility                                                  6,000
Net proceeds from stock options exercise                                               38
Proceeds from exercise of stock warrants                                               12
                                                                                 ---------         --------
  Net cash provided by financing activities                                             0            6,000
                                                                                 ---------         --------
Net (decrease) increase in cash and cash equivalents                                ($352)            $534
Cash and cash equivalents, beginning of year                                        3,653            1,367
                                                                                 ---------         --------
Cash and cash equivalents, end of year                                             $3,301           $1,901
                                                                                 =========         ========
SUPPLEMENTAL DISCLOSURE OF NONCASH
INVESTING AND FINANCING ACTIVITIES:
  Cash paid during the period for interest                                           $398              $51
                                                                                 =========         ========
</TABLE>

The  accompanying  notes are an integral  part of these  condensed  consolidated
financial statements.



<PAGE>




                               EMCORE CORPORATION
                       STATEMENTS OF SHAREHOLDERS' EQUITY
                                 (IN THOUSANDS)

<TABLE>
<CAPTION>

                                                                                           SHAREHOLDERS'     TOTAL
                                                          COMMON STOCK       ACCUMULATED       NOTES      SHAREHOLDERS'
                                                      SHARES      AMOUNT       DEFICIT      RECEIVABLES      EQUITY
                                                     ------------------------------------------------------------------
<S>                                                   <C>         <C>        <C>           <C>            <C>
BALANCE AT SEPTEMBER 30, 1995                           2,994       $16,638     ($14,982)         ($146)        $1,510

Issuance of common stock purchase warrants                            2,340                                      2,340
Notes receivable due from shareholders in connection
   with issuance of detachable warrants                                                            (152)         (152)
Net loss                                                                          (3,176)                      (3,176)
                                                     ------------------------------------------------------------------
BALANCE OF SEPTEMBER 30, 1996                           2,994        18,978      (18,158)          (298)           522

Issuance of common stock purchase warrants                            3,601                                      3,601
Issuance of common stock in initial public offering,
   net of issuance cost of $3,110                       2,875        22,765                                     22,765
Issuance of common stock on exercise of warrants           94           384                                        384
Issuance of common stock on exercise of stock              
   options                                                 35            54                                         54
Redemptions of notes receivable from shareholders                                                     32            32
Forgiveness of notes receivable from shareholder                                                      57            57
401(k) matching contribution                                2            35                                         35
Net loss                                                                          (5,619)                      (5,619)
                                                     ------------------------------------------------------------------
BALANCE OF SEPTEMBER 30, 1997                           6,000        45,817      (23,777)          (209)        21,831

Warrant exercise by conversion of sub-debt                 14            57                                         57
Warrant exercise in exchange for notes
   receivable                                           1,828         7,458                      (7,458)
Issuance of common stock in connection with
   the acquisition of MODE                              1,462        32,329                                     32,329
Compensatory stock issuances                                5            88                                         88
Stock option exercise                                      10            38                                         38
Net loss                                                                         (29,389)                     (29,389)
                                                     ------------------------------------------------------------------
BALANCE AT DECEMBER 31, 1997          (UNAUDITED)       9,319       $85,787     ($53,166)       ($7,667)        24,954
                                                     ==================================================================
</TABLE>

The  accompanying  notes are an integral  part of these  condensed  consolidated
financial statements.



<PAGE>

EMCORE CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS


NOTE 1.   INTERIM FINANCIAL INFORMATION

     The accompanying  unaudited condensed  consolidated financial statements of
EMCORE Corporation (the "Company") reflect all adjustments  considered necessary
by management to present fairly the Company's consolidated financial position as
of December  31, 1997 and December 31,  1996,  and the  consolidated  results of
operations and the  consolidated  cash flows for the quarters ended December 31,
1997,  and December  31, 1996.  All  adjustments  reflected in the  accompanying
unaudited condensed  consolidated financial statements are of a normal recurring
nature.  The results of operations for the three months ended December 31, 1997,
are not  necessarily  indicative  of the  results  for the  fiscal  year  ending
September 30, 1998, or any future interim period.


NOTE 2.   ACQUISITION

     On December 5, 1997, the Company  acquired all of the  outstanding  capital
stock of MicroOptical Devices, Inc. ("MODE") in exchange for 1,461,866 shares of
EMCORE common stock,  200,966 common stock  purchase  options  (exercise  prices
ranging  from  $0.43 to  $0.59),  and  47,188  common  stock  purchase  warrants
(exercise  prices  ranging  from  $4.32  to  $5.92).   The  purchase  price  was
approximately  $32,829,000  including direct  acquisition costs of approximately
$500,000.  The  acquisition  of MODE was recorded  using the purchase  method of
accounting.  Accordingly, the results of operations of the acquired business and
the fair  values of the  acquired  tangible  and  intangible  assets and assumed
liabilities are included in the Company financial statements as of the effective
date. The allocation of the fair value of the net assets acquired is as follows:

        Net tangible assets                                             $707,000
        Goodwill                                                       2,828,000
        Acquired in-process research and development                  29,294,000
                                                                     -----------
        Total purchase price                                         $32,829,000
                                                                     ===========

     The amount  allocated to acquired  in-process  research and development was
determined  through an  independent  valuation.  Amounts  allocated  to acquired
in-process  research and development were immediately  written off in the period
of acquisition. Goodwill is being amortized over a period of three years.

     The following unaudited pro forma basis financial  information reflects the
combined  results of  operations of the Company and MODE (in  thousands),  as if
MODE had been  acquired as of October 1, 1996 and  October 1, 1997.  The summary
includes the impact of certain  adjustments,  such as goodwill  amortization and
the number of shares outstanding.

                                             (Unaudited)          (Unaudited)
                                              Year ended         Quarter ended
                                          September 30, 1997   December 31, 1997
                                          ------------------   -----------------
     Revenue                                    $48,313            $12,457
     Net loss before extraordinary item           8,769                991
     Net loss                                     9,055                991
     Net loss, per share                          $1.35              $0.14
 

     The  unaudited  pro  forma  results  of  operations  are  not   necessarily
indicative of what actually would have occurred if the  acquisition had occurred
on October 1, 1996 or October 1, 1997.  In  addition,  the  unaudited  pro forma
results of operations are not intended to be a projection of future results that
might be achieved from the combined  entity.  The foregoing pro forma results of
operations does not reflect the non-recurring  write-off of acquired  in-process
research and development.


NOTE 3.   DEBT

     On March 31, 1997, the Company entered into a $10.0 million  revolving loan
agreement (the  "Agreement").  The Agreement bears interest at the rate of Prime
plus 50  basis  points,  subject  to  periodic  quarterly  decreases,  and has a
revolving  loan  maturity date and expires on September 30, 1998. As of December
31, 1997,  there were no borrowings  under the  Agreement,  however,  in January
1998, the Company borrowed $3.0 million at an interest rate of 8.25%.
<PAGE>

NOTE 4.   INVENTORIES

     The components of inventories consisted of the following (in thousands):

                                    AS OF                      AS OF
                              DECEMBER 31, 1997          SEPTEMBER 30, 1997
                              -----------------          ------------------

      Raw materials                 7,494                      $6,514
      Work-in-progress              1,674                         672
                                   ------                      ------
      Total                        $9,168                      $7,186
                                   ======                      ======


NOTE 5.   EARNINGS PER SHARE

     Basic  earnings per common share was  calculated  by dividing net income by
the weighted  average  number of common  shares  outstanding  during the period.
Diluted  earnings per share was  calculated by dividing net income by the sum of
the weighted  average  number of common shares  outstanding  plus all additional
common shares that would have been  outstanding if potentially  dilutive  common
shares had been issued.  The  following  table  reconciles  the number of shares
utilized in the  earnings  per share  calculations  for the three  month  period
ending December 31, 1997 and 1996, respectively.


                                            Three Months        Three Months
                                         Ended December 31,   Ended December 31,
                                                1997                 1996
                                         ------------------   ------------------
Net income ............................       ($29,389)             ($3,798)
                                              ========              =======
Earnings per common share - basic .....        ($ 4.15)              ($1.27)
                                               =======               ======
Earnings per common share - diluted ...        ($ 4.15)              ($0.86)
                                               =======               ======
Common Share - basic ..................          7,075                2,994
Effect of dilutive securities:
Stock options .........................           --                   --
Other .................................           --                  1,444
                                               -------               ------
Common shares - diluted ...............          7,075                4,438
                                               =======               ======


     Under the provisions of Securities and Exchange  Commission  Staff Bulletin
No. 64 ("SAB" No. 64), common stock and common stock  equivalents  issued by the
Company  within one year or in  contemplation  of the Company's  initial  public
offering  (the  "IPO") are treated as if they were  outstanding  for all periods
presented  prior  to  the  Company's  IPO.  After  the  IPO  is  effective,  the
determination  of common stock and  equivalents  has been  determined on a basis
consistent  with APB  Opinion  No. 15,  which  states  "outstanding  options and
warrants should be included in the EPS computation  ONLY if they have a dilutive
effect."


NOTE 6.   RELATED PARTIES

     In fiscal 1997, the Company entered into a non-exclusive and non-refundable
technology licensing and royalty agreement with Uniroyal Technology  Corporation
("UTC") for the process technology to develop and manufacture of high brightness
light emitting diodes ("LEDs").  Effective January 1998, UTC's  Chairman/CEO and
his son resigned from the Company's Board of Directors.
<PAGE>

ITEM 2.
MANAGEMENT'S  DISCUSSION  AND  ANALYSIS OF  FINANCIAL  CONDITION  AND RESULTS OF
OPERATIONS

OVERVIEW

     EMCORE,  founded  in 1984,  designs  and  develops  compound  semiconductor
materials and process  technology  and is a leading  manufacturer  of production
systems used to fabricate compound semiconductor wafers. Compound semiconductors
are  used  in  a  broad  range  of  applications  in  wireless   communications,
telecommunications,  computers,  and consumer and  automotive  electronics.  The
Company  provides  its  customers,  both  in the US  and  internationally,  with
materials  science  expertise,  process  technology  and compound  semiconductor
production  systems  that  enable  the  manufacture  of  commercial  volumes  of
high-performance  electronic  and  optoelectronic  devices.  In  response to the
growing need of its  customers  to cost  effectively  get to market  faster with
higher volumes of new and improved high  performance  products,  the Company has
expanded its product offerings to include the design, development and production
of compound semiconductor wafers and package-ready devices.

     On  December 5, 1997,  the Company  purchased  MicroOptical  Devices,  Inc.
("MODE").  MODE is one of the market  leaders in the design and  development  of
high-quality  optical components and subsystems based on vertical cavity surface
emitting laser ("VCSEL") technology,  which offers superior performance at lower
cost over conventional semiconductor laser technologies.  MODE's microlasers and
optical subsystems  provide design,  performance and significant cost advantages
over their  technical  predecessors  such as  edge-emitting  solid state lasers.
Through the  integration of VCSELs with leading OEM systems  design,  VCSELs are
expected to provide enhanced performance benefits to market applications such as
Internet  access,  onboard  photonics,  gigabit  ethernet,  local area networks,
microarea  networks,  DVD and  fiberoptic  switching.  MODE's  Gigalase(TM)  and
Gigarray(TM)  technology developments to date are currently being evaluated by a
variety  of  domestic  and  international  OEM  customers  in the  areas of data
communications, telecommunications, optical storage and sensing.

RESULTS OF OPERATIONS:

     REVENUES The Company's  first  quarter  revenue  increased  43.8% from $8.6
million  for the quarter  ended  December  31,  1996,  to $12.4  million for the
quarter ended December 31, 1997. The revenue  increase in the three month period
was primarily  attributable to the introduction of compound semiconductor wafers
and package-ready  devices into the Company's product lines, as well as payments
related to a licensing  agreement for product development  technology.  Revenues
relating to systems and  materials  accounted  for 54.4% and 45.6% for the three
months ended December 31, 1997 and 1996, respectively.  Systems revenue includes
production systems,  service and components.  Materials revenues include wafers,
devices  and  payments  for  product  development  technology  under a licensing
agreement.  International  sales accounted for approximately  44.2% and 64.3% of
revenues for the three months ended December 31, 1997 and 1996, respectively.

     The Company  believes  that in the future its  revenues  and  consequential
results of operations  in a quarterly  period could be impacted by the timing of
customer  development  projects and related  purchase  orders for the  Company's
varied  products,  new product  announcements  and releases by the Company,  and
economic   conditions   generally  and  the  compound   semiconductor   industry
environment specifically.

     COST OF SALES/GROSS PROFIT Cost of sales includes direct material and labor
costs,  allocated  manufacturing  and service  overhead,  and  installation  and
warranty  costs.  Gross profit  increased  from 21.7% of revenue for the quarter
ended  December 31, 1996, to 48.4% of revenue for the quarter ended December 31,
1997. The gross profit percentage increase was primarily  attributable to higher
margins on materials related revenues.

     SELLING,  GENERAL AND  ADMINISTRATIVE  Selling,  general and administrative
expenses increased by 39.6% from $2.2 million for the quarter ended December 31,
1996, to $3.1 million in the quarter ended  December 31, 1997.  The increase was
largely due to increases in sales  personnel  headcount to support both domestic
and foreign  markets and general  headcount  additions  to sustain the  internal
administrative  support necessary for the Company's increased business,  as well
as higher variable expenses attributable to increased revenues. In addition, the
Company  recognized  approximately  $71,000  of  goodwill  amortization  for the
quarter in  connection  with the  acquisition  of MODE on December 5, 1997. As a
percentage of revenue,  selling,  general and administrative  expenses decreased
from  25.6%  for the  first  quarter  of the  prior  year to 24.9% for the first
quarter of the current year.

     RESEARCH  AND  DEVELOPMENT  Research  and  development  expenses  increased
significantly from $2.3 million in the quarter ended December 31, 1996, to $32.1
million in the quarter ended  December 31, 1997.  Of this amount,  approximately
$29.3 million  pertained to the Company's  December 5, 1997,  one-time  non-cash
charge for acquired  in-process  research and development in connection with the
purchase of MODE. Absent this non-recurring charge, research and development was
$2.8  million,  or a 26.0%  increase over the first quarter of fiscal 1996. As a
percentage  of revenue,  excluding  the  one-time  non-cash  charge for acquired
in-process research and development, research and development expenses decreased
from  26.2%  for the  first  quarter  of the  prior  year to 23.0% for the first
quarter of the  current  year.  To  maintain  growth and  market  leadership  in
epitaxial  technology,  the Company  expects to continue to invest a significant
amount of its resources in research and development.

     OPERATING  INCOME (LOSS) Not  including the  operations of MODE acquired on
December 5, 1997 nor the one-time  non-cash charge of $29.3 million  relating to
the acquired  research and development,  operating profit increased $3.3 million
from a loss of $2.6 million in the quarter ended December 31, 1996, to income of
$0.7 million in the quarter ended December 31, 1997. Including MODE's operations
from the  date of  acquisition  and the  $29.3  million  charge,  the  Company's
operating  profit  decreased  $26.6  million  from a loss of $2.6 million in the
quarter ended December 31, 1996, to a loss of $29.2 million in the quarter ended
December 31, 1997. The change in operating loss is primarily due to the purchase
of MODE and  corresponding  one-time  non-cash  charge for  acquired  in-process
research and development.

     OTHER EXPENSE During fiscal 1996, the Company  issued  detachable  warrants
along with subordinated  notes to certain of its existing  shareholders.  In the
first quarter of fiscal year 1997, the Company also issued  detachable  warrants
in return for a $10.0 million demand note facility (the "Facility") guarantee by
a director of the Company,  affiliated with the Company's majority  shareholder,
who provided collateral for the Facility.  The Company  subsequently  assigned a
value to these detachable warrants using the Black-Scholes Option Pricing Model.
The Company recorded the subordinated  notes at a carrying value that is subject
to periodic  accretions,  using the interest method,  and reflected the Facility
detachable option value as a debt issuance cost. The consequent expense of these
warrant accretion amounts and the now terminated  Facility debt issuance cost is
charged to "Imputed  warrant  interest,  non-cash," and amounted to $1.0 million
and $91,000 for the  quarters  ended  December  31, 1996 and  December 31, 1997,
respectively.  As of December  31, 1996,  the Company had borrowed  $6.0 million
under the  Facility.  This  amount was repaid on March 31,  1997.  The  interest
expense under the Facility  resulted in higher stated  interest  expense for the
quarter ended December 31, 1996.

     NET INCOME/LOSS Excluding the operations of MODE and the one-time charge of
$29.3 million, net income increased $4.3 million from a net loss of $3.8 million
in the quarter  ended  December 31,  1996,  to net income of $0.5 million in the
quarter ended December 31, 1997.  Including  MODE's  operations from the date of
acquisition and the $29.3 million charge, the Company's net loss increased $25.6
million from a loss of $3.8 million in the quarter ended December 31, 1996, to a
loss of $29.4 million in the quarter ended December 31, 1997. This  year-to-date
loss  increase was primarily  attributable  to the  aforementioned  write-off of
acquired  in-process research and development in connection with the acquisition
of MODE on December 5, 1997.

BACKLOG

     The  Company's  order  backlog  decreased  6.7% from  $23.8  million  as of
December  31,  1996,  to $22.2  million as of  December  31,  1997.  The Company
includes in backlog only  customer  purchase  orders which have been accepted by
the Company and for which shipment dates have been assigned within the 12 months
to follow and  research  contracts  that are in process  or  awarded.  Wafer and
device  contract  agreements  extending  longer  than one year in  duration  are
included in backlog  only for the ensuing 12 months with respect to wafers and 3
months with respect to devices.  Some of these agreements  currently extend over
12 months. The Company receives partial advance payments or irrevocable  letters
of credit on most  production  system orders and has never  experienced an order
cancellation.  Although the Company has increased its capacity to meet continued
increased  production needs,  there can be no assurance that the Company will be
consistently able to increase its capacity to meet its scheduled needs.

     LIQUIDITY  AND CAPITAL  RESOURCES  Cash and cash  equivalents  decreased by
$352,000  from $3.7 million at September  30, 1997,  to $3.3 million at December
31, 1997.  For the three months ended  December 31, 1997,  net cash  provided by
operations amounted to $1.0 million,  primarily due to the Company's increase in
accounts  payable and  decrease in accounts  receivable  which was offset by the
Company's net losses  excluding  one-time  charges,  increase in inventory,  and
decrease in accrued expenses and advanced  billings.  For the three months ended
December  31,  1997,  net cash used in  investment  activities  amounted to $1.4
million due to purchase and manufacture of new equipment for the facilitation of
the  Company's  wafer and  package  ready  device  product  lines and clean room
modifications and enhancements.

     On March 31, 1997, the Company entered into a $10.0 million  revolving loan
(the  "Agreement").  The Agreement  bears  interest at the rate of Prime plus 50
basis points, subject to periodic quarterly decreases,  and has a revolving loan
maturity date and expires on September 30, 1998. As of December 31, 1997,  there
were no borrowings  under the Agreement,  however,  in January 1998, the Company
borrowed $3.0 million at an interest rate of 8.25%.

     The  Company  believes  that  its  current  liquidity,  together  with  the
Agreement,  should be  sufficient  to meet its cash  needs for  working  capital
through fiscal 1998.  However, if cash generated from operations is insufficient
to satisfy the Company's liquidity requirements,  the Company may be required to
raise  funds  through  equity  or debt  offerings  or obtain  additional  credit
facilities if possible.  Additional  funding may not be available when needed or
on terms  acceptable to the Company,  which could have a material adverse effect
on the Company's business financial conditions or operations.

     At December 31, 1997,  the Company  employed 307  full-time  employees,  up
50.5% from 204 as of December  31, 1996 and up 186.9% from the 107  employees at
December 31, 1995. The increase in the number of employees since the end of 1995
is a direct result of the Company's  increased  manufacturing  needs to meet the
demand for its compound semiconductor production systems and materials.  None of
the Company's employees are covered by a collective  bargaining  agreement.  The
Company considers its relationship with its employees to be good.

     OUTLOOK On December 5, 1997, the Company purchased MODE. MODE is one of the
market  leaders in the design and  development  of  high-quality  components and
subsystems  based  on VCSEL  technology,  which is  expected  to offer  superior
performance  and higher  efficiency  over  conventional  compound  semiconductor
technologies.

     MODE's microlasers and optical  subsystems provide design,  performance and
significant   cost  advantages  over  their  technical   predecessors   such  as
edge-emitting solid state lasers. Through the integration of VCSELs with leading
OEM systems design, VCSELs are expected to provide enhanced performance benefits
to market  applications  such as Internet  access,  onboard  photonics,  gigabit
ethernet,  local area  networks,  microarea  networks such as  chip-to-chip  and
board-to-board  applications,  DVD and fiberoptic switching. MODE's Gigalase(TM)
and Gigarray(TM)  technology  developments to date are currently being evaluated
by a variety of domestic and  international  OEM  customers in the areas of data
communications, telecommunications, optical storage and sensing.

     The  Company  believes  that  VCSEL  technology  may  address  a number  of
technical  bandwidth  challenges  applicable  to the  high-speed  computing  and
communications markets,  allowing  optoelectronic  applications to perform their
functions  at higher  speeds  with lower costs than  traditional  optoelectronic
systems. The Company believes that with the acquisition of MODE, it will be well
positioned to actively  participate in the  development  of the  next-generation
optoelectronic laser market which is estimated to grow to one billion dollars by
the year 2000.

     Under the terms of the agreement,  the Company issued  1,461,866  shares of
Common  Stock,  200,966  common stock  purchase  options and 47,118 common stock
purchase warrants in exchange of 100% of the outstanding  capital stock of MODE.
The  acquisition  purchase price amounted to  approximately  $32.8 million.  The
acquisition  was  recorded  under  the  purchase  method  of  accounting  and  a
significant  portion of the  purchase  price was taken as a  one-time  charge of
approximately  $29.3  million  by  the  Company  related  to  the  write-off  of
acquired in-process research and development.

     Historically  the  Company  has  generated  significant  revenues  from its
TurboDisc(TM)  product  line  from  Asian  customers.   Continued  economic  and
currency-related  uncertainty  in the region could impact the  Company's  future
TurboDisc(TM)  sales  in this  market.

     The Company believes it possess the technological  "know how" to capitalize
on all of these market  opportunities.  However,  there can be no assurance that
the  Company  will  maintain  sufficient  growth in sales  levels to support the
associated labor, equipment and facility costs.

INFORMATION RELATING TO FORWARD LOOKING STATEMENTS
     Management's  Discussion and Analysis of Financial Condition and Results of
Operations  includes  forward-looking  statements  that  reflect  the  Company's
current  expectations or beliefs concerning future results and events. The words
"expects", "intends", "believes",  "anticipates",  "likely", "will", and similar
expressions   identify   forward-looking   statements.   These   forward-looking
statements  are subject to certain  risks and  uncertainities  which could cause
actual  results and events to differ  materially  from those  anticipated in the
forward-looking statements.  Factors that might cause such a difference include,
but are not limited to,  statements  about future  financial  performance of the
Company and MODE and the effect of the  acquisition  on the Company's  business;
continued acceptance of the Company's MOCVD technologies,  as well as the market
success of VCSEL  technologies;  the Company's  ability to achieve and implement
the planned enhancements of products and services on a timely and cost-effective
basis  and  customer   acceptance  of  those  product   introductions;   product
obsolescence  due to  advances  in  technology  and  shifts  in  market  demand;
competition and resulting price  pressures;  business  conditions;  economic and
stock market  conditions,  particularly in the U.S., Europe and Japan, and their
impact on sales of the Company's  products and services;  risks  associated with
foreign operations,  including currency and political risks; and such other risk
factors as may have been or may be included  from time to time in the  Company's
reports filed with the Securities and Exchange Commission.





<PAGE>

PART II.  OTHER INFORMATION

ITEM 6.   EXHIBITS AND REPORTS ON FORM 8-K

(a) List of Exhibits:
                     11 - Statement of Computation of Per Share Amounts
                     27 - Financial Data Schedule

(b) Reports on Form 8-K:
                        Form 8-K  dated  December  22,  1997
                        Form 8-K/A dated December 24, 1997


<PAGE>


     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned thereunto duly authorized.

                               EMCORE CORPORATION


Date: February 13, 1998            By: /s/ Reuben F. Richards, Jr.
                                      ---------------------------------
                                      Reuben F. Richards, Jr.
                                      President and Chief Executive Officer

Date: February 13, 1998            By: /s/ Thomas G. Werthan
                                      ---------------------------------
                                      Thomas G. Werthan
                                      Vice President, Finance and Administration


<PAGE>


                                  EXHIBIT INDEX


EXHIBIT                     DESCRIPTION

11                          Statement of Computation of Per Share Amounts

27                          Financial Data Schedule





                                                                      EXHIBIT 11

                               EMCORE CORPORATION
                  STATEMENT OF COMPUTATION OF PER SHARE AMOUNTS
                    (IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)
                                   (Unaudited)

                                                            THREE MONTHS
                                                         ENDED DECEMBER 31,
                                                      1997                 1996
                                                      ----                 ----


Net loss                                            ($29,389)           ($3,798)
                                                    =========           ========

Basic earning per share calculation: 
Weighted average shares outstanding:
      Common stock                                     7,075              2,994
      Common stock equivalents (1)                                       
                                                    ---------           --------

Primary weighted average
      Common shares and equivalents                    7,075              2,994

Net loss per share                                    ($4.15)            ($1.27)
                                                    =========           ========


Fully diluted earnings per share calculation (2):
Weighted average shares outstanding:
      Common stock                                     7,075              2,994
      Common stock equivalents (1)                                        1,444
                                                    ---------           --------

Primary weighted average
      Common shares and equivalents                    7,075              4,438
                                                    =========           ========

Net loss per share                                    ($4.15)            ($0.86)
                                                    =========           ========

__________________
(1)  Under the provisions of Securities and Exchange  Commission  Staff Bulletin
     No. 64 ("SAB" No. 64), common stock and common stock equivalents  issued by
     the company within one year or in contemplation  of the Company's  offering
     are treated as if they were outstanding for all periods  presented prior to
     the Company's IPO. After the IPO is effective,  the determination of common
     stock and equivalents  has been  determined on a basis  consistent with APB
     Opinion No. 15, which states  "outstanding  options and warrants  should be
     included in the EPS computation only if they have a dilutive effect."
(2)  This calculation is submitted in accordance with Securities Exchange Act of
     1934  Release No. 9083  although not required by footnote 2 of paragraph 14
     of APB Opinion No. 15 because it results in dilution of less than 3%.



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS  SCHEDULE  CONTAINS  SUMMARY  FINANCIAL   INFORMATION  EXTRACTED  FROM  THE
CONSOLIDATED FINANCIAL STATEMENTS OF EMCORE CORPORATION FOR THE QUARTERLY PERIOD
ENDED  DECEMBER 31, 1997,  AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANCIAL STATEMENTS.
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS      
<FISCAL-YEAR-END>                          SEP-30-1998 
<PERIOD-END>                               DEC-31-1997 
<CASH>                                           3,551
<SECURITIES>                                         0 
<RECEIVABLES>                                    8,564 
<ALLOWANCES>                                     (707) 
<INVENTORY>                                      9,168 
<CURRENT-ASSETS>                                23,058 
<PP&E>                                          31,631
<DEPRECIATION>                                (12,389) 
<TOTAL-ASSETS>                                  46,139 
<CURRENT-LIABILITIES>                           12,382 
<BONDS>                                              0 
                                0 
                                          0 
<COMMON>                                        85,787 
<OTHER-SE>                                           0 
<TOTAL-LIABILITY-AND-EQUITY>                    46,139 
<SALES>                                         12,357 
<TOTAL-REVENUES>                                12,357 
<CGS>                                            6,376
<TOTAL-COSTS>                                    6,376 
<OTHER-EXPENSES>                                35,204 
<LOSS-PROVISION>                                     0 
<INTEREST-EXPENSE>                                 166 
<INCOME-PRETAX>                               (29,389) 
<INCOME-TAX>                                         0 
<INCOME-CONTINUING>                           (29,389) 
<DISCONTINUED>                                       0 
<EXTRAORDINARY>                                      0 
<CHANGES>                                            0 
<NET-INCOME>                                  (29,389) 
<EPS-PRIMARY>                                   (4.15) 
<EPS-DILUTED>                                   (4.15) 
                                           


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission